Danaparoid - CISMeF

Preferred Label : Danaparoid;

NCIt definition : A synthetic low molecular weight heparin (LMWH) derived from porcine gut mucosa, with anticoagulant activity. Upon administration, danaparoid binds to antithrombin III and inhibits the activity of activated factor X (factor Xa) and, to a lesser extent, activated factor II (thrombin) thereby preventing fibrin formation. Compared to heparin, danaparoid sodium exhibits a much higher ratio of anti-factor Xa activity to anti-factor IIa activity (22:1).;

UNII : BI6GY4U9CW;

CAS number : 308068-55-5;

NCI Metathesaurus CUI : CL1915383;

Codes from synonyms : 136;

Details

Origin ID

C200706;

UMLS CUI

C0259507;

Currated CISMeF NLP mapping
- Danaparoid [SMS substance]
- Danaparoid [ICD-11 Extension code]
- Danaparoid (substance) [SNOMED CT concept]
- danaparoid [MeSH Supplementary Concept]
- danaparoid [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Danaparoid (substance) [SNOMED CT concept]
- Product containing danaparoid (medicinal product) [SNOMED CT concept]
- danaparoid [MeSH Supplementary Concept]
- danaparoid [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- HemOnc Agent Terminology [NCIt concept]
has_salt_form
- Danaparoid Sodium [NCIt concept]
is_free_acid_or_base_form_of
- Danaparoid Sodium [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients